171 related articles for article (PubMed ID: 15318150)
1. [The teratogenicity of dermatological treatments].
Henno A; De La Brassinne M
Ann Dermatol Venereol; 2004; 131(6-7 Pt 1):599-605. PubMed ID: 15318150
[No Abstract] [Full Text] [Related]
2. [Local treatment of dermatoses in pregnancy].
Arnold WP; Boelen RE; van de Kerkhof PC
Ned Tijdschr Geneeskd; 1995 Jun; 139(23):1170-3. PubMed ID: 7791922
[No Abstract] [Full Text] [Related]
3. Thalidomide neurotoxicity in dermatological patients: the next "STEP".
Gaspari A
J Invest Dermatol; 2002 Nov; 119(5):987-8. PubMed ID: 12445181
[No Abstract] [Full Text] [Related]
4. Thalidomide.
Radomsky CL; Levine N
Dermatol Clin; 2001 Jan; 19(1):87-103. PubMed ID: 11155589
[TBL] [Abstract][Full Text] [Related]
5. Drug survival of thalidomide for dermatological conditions: A single-centre review.
Arasu A; Lee S; Chian Yeoh A; Ross G
Australas J Dermatol; 2021 Feb; 62(1):e107-e109. PubMed ID: 32627846
[No Abstract] [Full Text] [Related]
6. A practical guide to dermatological drug use in pregnancy.
Zip C
Skin Therapy Lett; 2006 May; 11(4):1-4. PubMed ID: 16732394
[TBL] [Abstract][Full Text] [Related]
7. [Local treatment of skin diseases in pregnant women].
de Groot AC; Korstanje MJ
Ned Tijdschr Geneeskd; 1995 Aug; 139(31):1609. PubMed ID: 7675148
[No Abstract] [Full Text] [Related]
8. [Modification of the effectiveness of contraceptives].
Köhn FM
Hautarzt; 1996 Mar; 47(3):225-6. PubMed ID: 8647708
[No Abstract] [Full Text] [Related]
9. Candidiasis of the skin and acne.
Courtenay M; Butler M
Nurs Times; 2002 Feb 28-Mar 6; 98(9):55-6. PubMed ID: 11917398
[No Abstract] [Full Text] [Related]
10. [Thalidomide].
Laffitte E; Revuz J
Ann Dermatol Venereol; 2000; 127(6-7):603-13. PubMed ID: 10930858
[No Abstract] [Full Text] [Related]
11. Thalidomide experience of a major Australian teaching hospital.
Crouch RB; Foley PA; Ng JC; Baker CS
Australas J Dermatol; 2002 Nov; 43(4):278-84. PubMed ID: 12423435
[TBL] [Abstract][Full Text] [Related]
12. [Retinoids in dermatopharmacology].
Amann PM; Merk HF; Baron JM
Hautarzt; 2014 Feb; 65(2):98-105. PubMed ID: 24419474
[TBL] [Abstract][Full Text] [Related]
13. [Retinoids and congenital malformations].
van der Schroeff JG
Ned Tijdschr Geneeskd; 1986 Apr; 130(14):622-3. PubMed ID: 3458029
[No Abstract] [Full Text] [Related]
14. Safety of important dermatological drugs (retinoids, immune suppressants, anti androgens and thalidomide) in reproductively active males with respect to pregnancy outcome: A brief review of literature.
Kumar P; Das A; Lal NR; Jain S; Ghosh A
Indian J Dermatol Venereol Leprol; 2018; 84(5):539-546. PubMed ID: 29998864
[TBL] [Abstract][Full Text] [Related]
15. [New indications for thalidomide?].
Tuinmann G; Hegewisch-Becker S; Hossfeld DK
Dtsch Med Wochenschr; 2001 Oct; 126(42):1178-82. PubMed ID: 11607859
[No Abstract] [Full Text] [Related]
16. An overview of the retinoids.
Boyd AS
Am J Med; 1989 May; 86(5):568-74. PubMed ID: 2653031
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide in dermatology.
Wines NY; Cooper AJ; Wines MP
Australas J Dermatol; 2002 Nov; 43(4):229-38; quiz 239-40. PubMed ID: 12423428
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide in dermatology. New indications for an old drug.
Calderon P; Anzilotti M; Phelps R
Int J Dermatol; 1997 Dec; 36(12):881-7. PubMed ID: 9466191
[No Abstract] [Full Text] [Related]
19. [Thalidomide in the treatment of cutaneous and systemic sarcoidosis].
Hoch O; Müller S; Büttner G; Mensing H
Hautarzt; 2001 Oct; 52(10 Pt 2):962-5. PubMed ID: 11715394
[TBL] [Abstract][Full Text] [Related]
20. [Topical therapy in pregnancy].
Zesch A
Hautarzt; 1990 Jul; 41(7):365-8. PubMed ID: 2205601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
